- Corporate Officers - R
- Renaud Ronald C Jr
Insider Trading History of Renaud Ronald C Jr
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Renaud Ronald C Jr since 2020.
This trader's CIK number is 1354434.
At the time of last reporting, Renaud Ronald C Jr was the CEO & President of Kailera Therapeutics, Inc.. (stock ticker symbol KLRA).
Also see all insider trading activities at Kailera Therapeutics, Inc..
Note that in the past
Renaud Ronald C JR also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Kailera Therapeutics, Inc. (KLRA) by Renaud Ronald C Jr
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | KLRA | 0 | $0 | 0 | $0 | 38,094 | $199,993 |
Yearly summary of insider trading at Cerevel Therapeutics Holdings, Inc. (CERE) by Renaud Ronald C Jr
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | CERE | 83,857 | $2,008,794 | 0 | $0 | 160,452 | $0 |
Yearly summary of insider trading at Translate Bio, Inc. (TBIO) by Renaud Ronald C Jr
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | TBIO | 0 | $0 | 954,053 | $36,254,014 | 14,665 | $111,052 |
| 2020 | TBIO | 0 | $0 | 0 | $0 | 53,007 | $416,900 |
Insider trading activities at 3 companies by Renaud Ronald C Jr:
1. Kailera Therapeutics, Inc. (KLRA)
2. Cerevel Therapeutics Holdings, Inc. (CERE)
3. Translate Bio, Inc. (TBIO)
Table 1. Insider trading of Kailera Therapeutics, Inc. (KLRA) by Renaud Ronald C Jr
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-06-09 | KLRA | Option Ex | 38,094 | 5.25 | 199,993 |
Table 2. Insider trading of Cerevel Therapeutics Holdings, Inc. (CERE) by Renaud Ronald C Jr
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-12-19 | CERE | Option Ex | 160,452 | .00 | 0 |
| 2023-08-03 | CERE | Buy | 83,857 | 23.95 | 2,008,794 |
Table 3. Insider trading of Translate Bio, Inc. (TBIO) by Renaud Ronald C Jr
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-09-14 | TBIO | Sale | 954,053 | 38.00 | 36,254,014 |
| 2021-04-07 | TBIO | Option Ex | 9,026 | 7.39 | 66,702 |
| 2021-01-14 | TBIO | Option Ex | 5,639 | 7.87 | 44,350 |
| 2020-11-16 | TBIO | Option Ex | 53,007 | 7.87 | 416,900 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Renaud Ronald C Jr
(CEO & President of Kailera Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.